Medical cannabis is a boon to many people across Colorado. It allows them to sleep, eat, deal with anxiety and pain, and function as well as possible. Unfortunately, Colorado Bill 1317 – which seeks to make cannabis less accessible to children – will likely make medical access more difficult as well.
While the spirit of the bill might be in the right place, it’s filled with overreach. If passed, it’s possible that medical cannabis patients will have their access and supply limited. Let’s take a look at what’s in the bill and why it’s a problem, particularly for concentrate users.
What’s in Bill 1317?
One of the main points of the bill is to limit the access of underage (under 21 years) consumption of medical cannabis, due to the potency of these products. The problem is that the bill does this by targeting THC amounts and potency specifically, which will impact concentrates and a lot of other products collaterally. It does this by limiting the amount of concentrate per day, among other methods.
Limiting daily concentrate amounts
Right now, a medical marijuana patient in Colorado can purchase up to 40g, but the bill will limit purchases to only 10g. For patients between 18 and 20, the limit is further dialed down to only 2 grams. While specific options exist to allow homebound and other patients to have broader access, in general, this limit hampers medical cannabis patient rights.
Colorado Bill 1317 will also limit the amount of these products to .1 gram servings, similar to how edibles are sold. This restricts your ability to use them as you wish, instead of keeping your doses to a strict, legally controlled limit.
Tracking cannabis sales and patients
The bill also allows for the tracking of purchases to prevent patients from ignoring the limits. Gathering data on patients’ medicine usage is a dangerous road to go down for lawmakers, essentially putting medical cannabis patients on another list to be monitored. 1317 will track your purchases, where and how much cannabis you buy, and your doctor’s recommendations.
Research and amendments
Finally, the bill calls for monitoring and research on high-potency cannabis products to determine their effects, particularly on patients younger than 25. Additionally, toxicology will be done on all suicide or “non-natural” deaths of patients under 25 to determine if there is a pattern between these casualties and high-potency cannabis use. It should be noted that the bill allows for changes to be made if the data suggests a correlation between deaths in young people and cannabis use.
What will happen if Colorado Bill 1317 passes?
If the bill passes, you will need to be prepared to jump through more hoops to get the cannabis concentrates you need. Your purchases will be even more tightly controlled and monitored, especially if you’re a younger patient. For those who simply enjoy dabs, this will affect you, too – the bill applies not just to medical but all high-potency cannabis products.
Though the bill doesn’t seek to ban or remove cannabis concentrates or other THC products, it does create a scenario that is more restrictive to medical marijuana users. For someone who simply needs cannabis to function daily, this is unfortunate.
If you have concerns about how the bill will affect your access to cannabis concentrates or other medical cannabis products, speak with your doctor. In the current draft of the bill, there is a provision that allows for certain patients to have their access increased beyond the proposed cap, and it would require a doctor’s authorization and recommendation. Finally, you can call your local legislation to voice your concerns over the changes to cannabis sales in Colorado.